Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.

Vassall A, Pickles M, Chandrashekar S, Boily MC, Shetty G, Guinness L, Lowndes CM, Bradley J, Moses S, Alary M; Charme India Group, Vickerman P.

Lancet Glob Health. 2014 Sep;2(9):e531-40. doi: 10.1016/S2214-109X(14)70277-3. Epub 2014 Aug 27.

PMID:
25304420
[PubMed - in process]
Free Article
2.

Optimal Allocation of Resources in Female Sex Worker Targeted HIV Prevention Interventions: Model Insights from Avahan in South India.

Panovska-Griffiths J, Vassall A, Prudden HJ, Lépine A, Boily MC, Chandrashekar S, Mitchell KM, Beattie TS, Alary M, Martin NK, Vickerman P.

PLoS One. 2014 Oct 1;9(10):e107066. doi: 10.1371/journal.pone.0107066. eCollection 2014.

PMID:
25271808
[PubMed - in process]
Free PMC Article
3.

Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis.

Mountain E, Mishra S, Vickerman P, Pickles M, Gilks C, Boily MC.

PLoS One. 2014 Sep 29;9(9):e105645. doi: 10.1371/journal.pone.0105645. eCollection 2014.

PMID:
25265158
[PubMed - in process]
Free PMC Article
4.

The HIV care cascade and antiretroviral therapy in female sex workers: implications for HIV prevention.

Mountain E, Pickles M, Mishra S, Vickerman P, Alary M, Boily MC.

Expert Rev Anti Infect Ther. 2014 Oct;12(10):1203-19. doi: 10.1586/14787210.2014.948422. Epub 2014 Aug 30.

PMID:
25174997
[PubMed - in process]
5.

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study.

Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M.

Vaccine. 2014 Oct 7;32(44):5845-53. doi: 10.1016/j.vaccine.2014.07.099. Epub 2014 Aug 12.

PMID:
25131743
[PubMed - in process]
Free Article
6.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2014 Jan;2(1):e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.

PMID:
25104632
[PubMed - in process]
Free Article
7.

Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysis.

Pickles M, Boily MC, Vickerman P, Lowndes CM, Moses S, Blanchard JF, Deering KN, Bradley J, Ramesh BM, Washington R, Adhikary R, Mainkar M, Paranjape RS, Alary M.

Lancet Glob Health. 2013 Nov;1(5):e289-99. doi: 10.1016/S2214-109X(13)70083-4. Epub 2013 Sep 30.

PMID:
25104493
[PubMed - in process]
Free Article
8.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2013 Dec 10;2(1):23-34.

PMID:
25083415
[PubMed]
Free PMC Article
9.

An action agenda for HIV and sex workers.

Beyrer C, Crago AL, Bekker LG, Butler J, Shannon K, Kerrigan D, Decker MR, Baral SD, Poteat T, Wirtz AL, Weir BW, Barré-Sinoussi F, Kazatchkine M, Sidibé M, Dehne KL, Boily MC, Strathdee SA.

Lancet. 2014 Jul 21. pii: S0140-6736(14)60933-8. doi: 10.1016/S0140-6736(14)60933-8. [Epub ahead of print] Review.

PMID:
25059950
[PubMed - as supplied by publisher]
10.

Global epidemiology of HIV among female sex workers: influence of structural determinants.

Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, Reza-Paul S, Lau J, Deering K, Pickles MR, Boily MC.

Lancet. 2014 Jul 21. pii: S0140-6736(14)60931-4. doi: 10.1016/S0140-6736(14)60931-4. [Epub ahead of print] Review.

PMID:
25059947
[PubMed - as supplied by publisher]
11.

Positive impact of increases in condom use among female sex workers and clients in a medium HIV prevalence epidemic: modelling results from Project SIDA1/2/3 in Cotonou, Benin.

Williams JR, Alary M, Lowndes CM, Béhanzin L, Labbé AC, Anagonou S, Ndour M, Minani I, Ahoussinou C, Zannou DM, Boily MC.

PLoS One. 2014 Jul 21;9(7):e102643. doi: 10.1371/journal.pone.0102643. eCollection 2014.

PMID:
25047804
[PubMed - in process]
Free PMC Article
12.

Validation of the modes of transmission model as a tool to prioritize HIV prevention targets: a comparative modelling analysis.

Mishra S, Pickles M, Blanchard JF, Moses S, Shubber Z, Boily MC.

PLoS One. 2014 Jul 9;9(7):e101690. doi: 10.1371/journal.pone.0101690. eCollection 2014.

PMID:
25014543
[PubMed - in process]
Free PMC Article
13.

The HIV Modes of Transmission model: a systematic review of its findings and adherence to guidelines.

Shubber Z, Mishra S, Vesga JF, Boily MC.

J Int AIDS Soc. 2014 Jun 23;17:18928. doi: 10.7448/IAS.17.1.18928. eCollection 2014.

PMID:
24962034
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Who mixes with whom among men who have sex with men? Implications for modelling the HIV epidemic in southern India.

Mitchell KM, Foss AM, Prudden HJ, Mukandavire Z, Pickles M, Williams JR, Johnson HC, Ramesh BM, Washington R, Isac S, Rajaram S, Phillips AE, Bradley J, Alary M, Moses S, Lowndes CM, Watts CH, Boily MC, Vickerman P.

J Theor Biol. 2014 Aug 21;355:140-50. doi: 10.1016/j.jtbi.2014.04.005. Epub 2014 Apr 13.

PMID:
24727187
[PubMed - in process]
Free PMC Article
15.

Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?

Jit M, Choi YH, Laprise JF, Boily MC, Drolet M, Brisson M.

Vaccine. 2014 May 30;32(26):3237-42. doi: 10.1016/j.vaccine.2014.03.098. Epub 2014 Apr 13.

PMID:
24726246
[PubMed - in process]
16.

Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention context.

Mishra S, Mountain E, Pickles M, Vickerman P, Shastri S, Gilks C, Dhingra NK, Washington R, Becker ML, Blanchard JF, Alary M, Boily MC; Strategic Epi-ART in India Modelling Team.

AIDS. 2014 Jan;28 Suppl 1:S61-72. doi: 10.1097/QAD.0000000000000109.

PMID:
24468948
[PubMed - indexed for MEDLINE]
17.

Modelling in concentrated epidemics: informing epidemic trajectories and assessing prevention approaches.

Boily MC, Shubber Z.

Curr Opin HIV AIDS. 2014 Mar;9(2):134-49. doi: 10.1097/COH.0000000000000036. Review.

PMID:
24468893
[PubMed - indexed for MEDLINE]
18.

Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.

Dimitrov D, Boily MC, Brown ER, Hallett TB.

PLoS One. 2013 Nov 25;8(11):e80927. doi: 10.1371/journal.pone.0080927. eCollection 2013. Review.

PMID:
24282559
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine.

Drolet M, Laprise JF, Boily MC, Franco EL, Brisson M.

Int J Cancer. 2014 May 1;134(9):2264-8. doi: 10.1002/ijc.28541. Epub 2013 Oct 31.

PMID:
24174175
[PubMed - indexed for MEDLINE]
20.

Population-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settings.

Dimitrov D, Boily MC, Marrazzo J, Beigi R, Brown ER.

PLoS One. 2013 Sep 16;8(9):e73770. doi: 10.1371/journal.pone.0073770. eCollection 2013.

PMID:
24066069
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk